Back to Agenda
Session 5 Track 3: From AI Experiment to Strategic Advantage: Future-Proofing MSL Engagement
Session Chair(s)
Patrina Pellett, PhD
Co-CEO, MSL Mastery, United States
Generative AI (GenAI) is no longer an experiment: it is becoming a strategic advantage for Medical Affairs teams that know how to use it effectively. Organizations that continue using AI in random or unstructured ways risk being left behind, while those that adopt a structured, scalable approach can transform how MSLs prepare, engage, and follow up with healthcare providers. This interactive workshop equips participants with a practical prompting framework and a set of plug-and-play prompts aligned to the full MSL engagement process. Attendees will gain hands-on experience across three stages of the workflow:
Participants will practice adapting prompts in small groups, see live demonstrations of GenAI in action, and explore how these applications can be implemented responsibly within existing guardrails. In parallel, Medical Affairs leaders will consider strategies to scale adoption, through shared frameworks and training programs that turn AI from a collection of experiments into an enterprise-level capability.
Learning Objective : At the conclusion of this session, participants should be able to:- Apply a structured prompting framework to Medical Affairs use cases
- Practice creating and adapting plug-and-play prompts for MSL engagement scenarios
- Identify strategies for leaders to scale AI adoption into enterprise-level capability
Speaker(s)
Shane Bemiller, PhD
Associate Director, (East), Endocrinology Field Medical, Recordati Rare Diseases, United States
Speaker
Tom Peddicord, PharmD
Senior Director, Payer and Immunology MSLs, Argenx, United States
Speaker
Have an account?